Sara Nik's Stock Coverage
| KTTAPasithea Therapeutics Corp | Nov 05, 2026 | BUY | Reiterated | $3.00 | 14Ratings | -14.45% | ||
| CANTACantargia AB | Nov 04, 2026 | BUY | Reiterated | kr12.00 | 12Ratings | -43.72% | ||
| EIKNEikon Therapeutics, Inc. | Oct 26, 2026 | BUY | Reiterated | $23.00 | 2Ratings | -25.20% | ||
| MBRXMoleculin Biotech | Sep 29, 2026 | BUY | Reiterated | $60.00 | 20Ratings | -80.44% | ||
| TVRDTvardi Therapeutics | Aug 21, 2026 | BUY | Reiterated | $9.00 | 5Ratings | -66.60% | ||
| CRISCuris | Aug 17, 2026 | BUY | Reiterated | $43.00 | 10Ratings | -85.99% | ||
| KAPAKairos Pharma, Ltd. | Aug 13, 2025 | BUY | Reiterated | $12.00 | 1Ratings | -66.30% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Sara Nik activity FAQ
What is the performance of Sara Nik's recommendations?
The percentage of profitable recommendations made by Sara Nik is 18.18%, and the average return per transaction is -25.30%.
What stocks does Sara Nik cover?
What was Sara Nik's most profitable rating?
Sara Nik’s most profitable rating was a buy on CDTX stock on Jun 18, 2025. The return on the trade was 800.00%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here